You just read:

Daily Blood Glucose Measures in Phase 3 Clinical Trials Demonstrated Better Stability with Sanofi's Toujeo® vs. Insulin Glargine 100 Units/mL

News provided by

Sanofi

Sep 13, 2017, 07:00 ET